Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus

Pharmacotherapy

Volumn 30, Issue 4, 2010, Pages

  Kang Birken, S Lena ^a,b   Castel, Uldine ^a   Prichard, John G ^a  

^a Ventura County Public Health   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Doxycycline; HIV; Human immunodeficiency virus; Neurosyphilis

Indexed keywords

DOXYCYCLINE; PENICILLIN G; VIRUS RNA;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; DIZZINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MALE; MALE HOMOSEXUAL; MORNING DOSAGE; NEUROSYPHILIS; NONHUMAN; PHOTOSENSITIVITY; TREATMENT RESPONSE; VENEREAL DISEASE REACTION TEST;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUROSYPHILIS; TREATMENT OUTCOME;

EID: 77950451969     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.4.418     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. Primary and secondary syphilis - United States, 2003-2004. MMWR Morb Mortal Wkly Rep 2006;55:269-273
2. Centers for Disease Control and Prevention. Primary and secondary syphilis among men who have sex with men - New York City, 2001. MMWR Morb Mortal Wkly Rep 2002;51:853-856
3. Wong W, Chaw J, Kent C, Klausner J. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis 2003;32:458-463
4. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007;44:1222-1228
5. Centers for Disease Control and Prevention. Symptomatic early neurosyphilis among HIV-positive men who have sex with men - four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 2007;56:625-628
6. Workowski KA, Berman SM. Sexually transmitted disease treatment guidelines, 2006. MMWR Recomm Rep 2006;55:1-94.
7. Dowell M, Ross P, Musher DM, et al. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med 1992;93:481-488
8. Kingston M, French P, Goh B, et al. United Kingdom national guidelines on the management of syphilis, 2008. Int J STD AIDS 2008;19:729-740
9. Marr CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004;189:369-376
10. Ghanem KG, Moore RD, Rompalo AM, et al. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008;22:1145-1151
11. Ghanem KG, Moore RD, Rompalo AM, et al. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009;48:816-821
12. Norris SJ, Edmondson DG. In vitro culture system to determine MICs and MBCs of antimicrobial agents against Treponema pallidum subsp. pallidum (Nichols strain). Antimicrob Agents Chemother 1988;32:68-74.
13. Onoda Y. Therapeutic effect of oral doxycycline on syphilis. Brit J Vener Dis 1979;55:110-115
14. Barza M, Brown RB, Shanks C, et al. Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother 1975;8:713-730
15. Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 1985;28:347-348
16. Malone JL, Wallace MR, Hendrick BB, et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995;99:55-63.